Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Vaccine-Makers Edge Higher as Regulators OK Boosters for All Adults  

Published 11/22/2021, 10:06 AM
Updated 11/22/2021, 10:08 AM
© Reuters

By Dhirendra Tripathi

Investing.com – Shares of vaccine-makers traded higher on Monday after regulators approved boosters of their Covid-19 vaccines for all adults.

Moderna (NASDAQ:MRNA) and BioNTech (NASDAQ:BNTX) each traded around 2% higher, while Pfizer (NYSE:PFE), the German company’s partner in development and marketing of their Covid-19 vaccine, rose 0.3%.

Both the Centers for Disease Control and Prevention and the Food and Drug Administration Friday gave their nod to extra doses of their Covid-19 vaccines for people at least six months after their second shot.

Boosters were earlier advised for adults 65 and older and other vulnerable people.

Cases in some states have risen again lately soon after the Delta variant, the most rapidly-spreading of all coronaviruses, seemed to be waning.

Adults who got the single-dose Johnson & Johnson (NYSE:JNJ) vaccine were already eligible for Pfizer-BioNTech and Moderna boosters.

J&J stock traded 0.3% lower. The company is currently in the process of splitting its consumer health business into a separately listed entity.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.